1 |
Asano, N. 2003. Glycosidase inhibitors: Update and perspectives on practical use. Glycobiology 13, 93R-104R.
|
2 |
Fischer, P., M. Collin, G. Karlsson, W. James, T. Butters, S. Davis, S. Gordon, R. Dwek, and F. Platt. 1995. The -glucosidase inhibitor, N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J. Virol. 69, 5791-5797.
|
3 |
Kornfeld, R. and S. Kornfeld. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54, 631-664
|
4 |
O'Dea, K. and J. Turton. 1985. Optimum effectiveness of intestinal -glucosidase inhibitors. Am J Clin Nutr. 41, 511-516.
|
5 |
Sunkara, P., T. Bowlin, P. Liu, and A. Sjoerdsma. 1987. Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing. Biochem. Biophys. Res. Commun. 148, 206-210
|
6 |
Pan, Y., J. Ghidoni, and D. Elbein. 1993. The effects of castanospermine and swainsonine on the activity and synthesis of intestinal sucrase. Arch. Biochem. Biophys. 303, 134-144
|
7 |
Cenci di Bello, I., G. Fleet, K. Namgoong, K. Tadano, and B. Winchester. 1989. Structure-activity relationship of swainsonine: inhibition of human -mannosidase by swainsonine analogues. Biochem. J. 259, 855-861.
|
8 |
Molyneux, R., R. McKenzie, B. O’Sullivan, and A. Elbein. 1995. Identification of the glycosidase inhibitors swainsonine and calystegine B2 in weir vine and correlation with toxicity. J. Nat. Prod. 58, 878-886
|
9 |
Molyneux, R., R. Nash, and N. Asano. 1996. The chemistry and biological activity of calystegines and related nortropane alkaloids, p. 303-343. In S. Pelletier (ed.), Alkaloids: Chemical and Biological Perspectives, 11. Elsevier Science Ltd, Oxford, UK
|
10 |
Jacob, G.S. 1995. Glycosylation inhibitors in biology and medicine. Curr. Opin. Struct. Biol. 5, 605-611
|
11 |
Min, B.S., J.J. Gao, N. Nakamura, and M. Hattori. 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull. 48, 1026-1033
|
12 |
Watson, A., G. Fleet, N. Asano, R. Molyneux, and R. Nash. 2001. Polyhydroxylated alkaloids-natural occurrence and therapeutic applications. Phytochemistry 56, 265-295
|
13 |
Murai, A., K. Iwamura, M. Takada, K. Ogawa, T. Usui, and J. Okumura. 2002. Control of postprandial hyperglycaemia by galactosyl maltobionolactone and its novel anti-amylase effect in mice. Life Sci. 71, 1405-1415
|
14 |
Saul, R., J. Chambers, R. Molyneux, and A. Elbein. 1983. Castanospemine, a tetrahydroxylated alkaloid that inhibits -glucosidase and -glucocerebrosidase. Arch. Biochem. Biophys. 221, 593-597.
|
15 |
Hikino, H., C. Konno, Y. Mirin, and T. Hayashi. 1985. Isolation and hypoglycemic activity of Ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Pla. Med. 51, 339-340
|